Related Experiment Video
Updated: May 17, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Use of antifungal drugs in hematology
1Universidade Federal do Rio de Janeiro - UFRJ, Rio de Janeiro, RJ, Brazil.
Abstract:
Invasive fungal disease represents a major complication in hematological patients. Antifungal agents are frequently used in hematologic patients for different purposes. In neutropenic patients, antifungal agents may be used as prophylaxis, as empiric or preemptive therapy, or to treat an invasive fungal disease that has been diagnosed. The hematologist must be familiar with the epidemiology, diagnostic tools and strategies of antifungal use, as well as the pharmacologic proprieties of the different antifungal agents. In this paper the principal antifungal agents used in hematologic patients will be discussed as will the clinical scenarios where these agents have been used.
Insights
Hematology patients often develop invasive fungal disease. This review covers antifungal agents, their uses in prophylaxis and treatment, and key properties for hematologists.
Area of Science:
- Hematology
- Mycology
- Pharmacology
Background:
- Invasive fungal disease is a significant complication in patients with hematological conditions.
- Antifungal agents are integral to managing these patients, used for prophylaxis, empiric, preemptive, or therapeutic purposes.
- Hematologists require comprehensive knowledge of fungal disease epidemiology, diagnostics, and antifungal pharmacodynamics.
Purpose of the Study:
- To review the principal antifungal agents used in hematological patients.
- To discuss the clinical scenarios necessitating antifungal use in this population.
- To provide hematologists with essential information on antifungal strategies.
Main Methods:
- Literature review of antifungal agents and their application in hematology.
- Discussion of epidemiological data and diagnostic approaches for invasive fungal disease.
- Analysis of pharmacologic properties and clinical usage patterns of antifungals.
Main Results:
- Key antifungal agents and their specific roles in hematological care are detailed.
- Clinical contexts for antifungal prophylaxis, empiric, preemptive, and treatment strategies are outlined.
- Pharmacological profiles and practical considerations for antifungal selection are presented.
Conclusions:
- Effective management of invasive fungal disease in hematology patients relies on understanding antifungal agents and their appropriate application.
- Hematologists must be well-versed in antifungal pharmacology and clinical guidelines to optimize patient outcomes.
- This review serves as a guide to antifungal use in hematological contexts.
Related Concept Videos
Antifungal Agents
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Inhibitors of Viral Protein Synthesis
Anthelminthic Agents
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

